dc.contributor.author | Linton, KM | en_US |
dc.contributor.author | Specht, L | en_US |
dc.contributor.author | Pavlovsky, A | en_US |
dc.contributor.author | Thompson, CA | en_US |
dc.contributor.author | Kimby, E | en_US |
dc.contributor.author | de Jong, D | en_US |
dc.contributor.author | Nastoupil, LJ | en_US |
dc.contributor.author | Cottereau, A-S | en_US |
dc.contributor.author | Casulo, C | en_US |
dc.contributor.author | Sarkozy, C | en_US |
dc.contributor.author | Okosun, J | en_US |
dc.date.accessioned | 2024-01-25T11:36:57Z | |
dc.date.available | 2023-06-17 | en_US |
dc.date.issued | 2023 | en_US |
dc.identifier.issn | 0278-0232 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/94212 | |
dc.relation.ispartof | HEMATOLOGICAL ONCOLOGY | en_US |
dc.rights | This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. | |
dc.subject | follicular lymphoma | en_US |
dc.subject | immunochemotherapy | en_US |
dc.subject | personalized therapy | en_US |
dc.subject | POD24 | en_US |
dc.subject | risk factors | en_US |
dc.title | Personalised therapy in follicular lymphoma - is the dial turning? | en_US |
dc.type | Article | |
dc.rights.holder | © 2023 The Authors. Hematological Oncology published by John Wiley & Sons Ltd. | |
dc.identifier.doi | 10.1002/hon.3205 | en_US |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:001033716900001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |